Leaderboards/Vascular Malformations and Hemangiomas

Vascular Malformations and Hemangiomas

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Papers

Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances

Journal of Clinical Investigation|2024

64 cit.

Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C Mutation

New England Journal of Medicine|2024

34 cit.

Publication in Signal Transduction and Targeted Therapy (2024) [25 citations, W4399711928]

Signal Transduction and Targeted Therapy|2024

25 cit.

Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors

Angiogenesis|2024

22 cit.

PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations

Circulation|2025

5 cit.

Publication in Journal of Vascular Anomalies (2024) [1 citation, W4394810843]

Journal of Vascular Anomalies|2024

1 cit.

Image pre-processing impact on generative model performance for Unsupervised Venous Malformation Segmentation

Computer Methods and Programs in Biomedicine|2026

1 cit.

Enhancing End-To-End Autonomous Driving through Loss Function Optimization

Unknown Journal|2025

0 cit.

Radiological phenotyping of patients with PIK3CA mutation-associated overgrowth syndrome and algorithms development for semi-automated lesion segmentation

theses.fr (ABES)|2025

0 cit.

Radiological Evaluation of the Natural History of PIK3CA-Related Overgrowth Spectrum (PROS)

medRxiv|2026

0 cit.

Emerging Leaders

Drafting the new consensus

Papers

Uterine Inflammatory Myofibroblastic Tumors

The American Journal of Surgical Pathology|2022

32 cit.

MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ

Nature Communications|2023

30 cit.

NRASQ61R mutation in human endothelial cells causes vascular malformations

Angiogenesis|2022

25 cit.

ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

Arteriosclerosis Thrombosis and Vascular Biology|2023

25 cit.

Endothelial cell polarity and extracellular matrix composition require functional ATP6AP2 during developmental and pathological angiogenesis

JCI Insight|2022

19 cit.

Current induced hidden states in Josephson junctions

Nature Communications|2024

19 cit.

Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function

Frontiers in Cell and Developmental Biology|2023

18 cit.

Focal nodular hyperplasia–like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation

Human Pathology|2023

17 cit.

Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance

Scientific Reports|2022

16 cit.

Activity of a TIE2 inhibitor (rebastinib) in a patient with a life‐threatening cervicofacial venous malformation

Pediatric Blood & Cancer|2023

12 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

John B. Mulliken

Boston University

Ilona J. Frieden

University of California, San Francisco

Miikka Vikkula

Unknown

Julie Glowacki

Brigham and Women's Hospital

Joyce Bischoff

Harvard University

Leslie G. Biesecker

National Institutes of Health

Michael Detmar

Harvard University

Arin K. Greene

Boston Children's Hospital

Martín C. Mihm

Harvard University

Denise M. Adams

Children's Hospital of Philadelphia

Papers

Hemangiomas and Vascular Malformations in Infants and Children

Plastic & Reconstructive Surgery|1982

3.3k cit.

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Genetics in Medicine|2013

2.5k cit.

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

PubMed|1969

2.1k cit.

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

Nature Medicine|2001

1.7k cit.

A Mosaic Activating Mutation in <i>AKT1</i> Associated with the Proteus Syndrome

New England Journal of Medicine|2011

887 cit.

GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas

Human Pathology|2000

847 cit.

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies

PEDIATRICS|2016

830 cit.

Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2

Cell|1996

809 cit.

Aging Cell|2008

797 cit.

Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations

The American Journal of Human Genetics|2003

750 cit.

Reagents for Vascular Malformations and Hemangiomas

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 70

CD20 (E3N7O) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#35811$465

View Evidence →

Cell Signaling TechnologyEvidence 67

Phospho-Akt (Thr308) (C31E5E) Rabbit Monoclonal Antibody

#2965$197,979

View Evidence →

Agilent/Dako

Universal Negative Control for IR-Series Rabbit Primary Antibodies

#IR600

View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 63

Integrin beta6 (E4M9P) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 6 papers

#63615$465

View Evidence →

Cell Signaling Technology

5-Carboxylcytosine (5-caC) (D7S8U) Rabbit Monoclonal Antibody

D2-40